Jennifer Thomas
gethealthtipsorg
Amicus to delay filing for U.S. marketing rights for lead drug
(Reuters) - Amicus Therapeutics Inc said it was unlikely to submit a U.S. marketing application for its lead drug, to treat Fabry disease, by the end of 2015 as expected, after U.S. health regulators asked for a more comprehensive analysis of trial data.
feeds.reuters.com/~r/reuters/healthNews/~3/iNYquCV3MRU/st...
26
views
0
faves
0
comments
Uploaded on October 2, 2015
Amicus to delay filing for U.S. marketing rights for lead drug
(Reuters) - Amicus Therapeutics Inc said it was unlikely to submit a U.S. marketing application for its lead drug, to treat Fabry disease, by the end of 2015 as expected, after U.S. health regulators asked for a more comprehensive analysis of trial data.
feeds.reuters.com/~r/reuters/healthNews/~3/iNYquCV3MRU/st...
26
views
0
faves
0
comments
Uploaded on October 2, 2015